Evidence map›Paper›PMID 28230778›Full record

ArticleInternational journal of molecular sciences2017

Caffeic Acid Expands Anti-Tumor Effect of Metformin in Human Metastatic Cervical Carcinoma HTB-34 Cells: Implications of AMPK Activation and Impairment of Fatty Acids De Novo Biosynthesis.

Malgorzata Tyszka-Czochara, Pawel Konieczny, Marcin Majka

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03070262 (Caffeic Acid for Advanced Esophageal Squamous Cell Cancer), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03070262 phase3unknown statusnot on this map

Caffeic Acid for Advanced Esophageal Squamous Cell Cancer: A Randomized, Double-blind, and Multicenter Trial in Chinese Patients

TypeinterventionalSponsorThe First Affiliated Hospital of Henan University of Science and TechnologyRan2017 to 2021Enrolled300ConditionsEsophagus CancerArmsCA, placebo group
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Journal of Taibah University Medical Sciences · 2025
    Article
  7. Adjuvant Properties of Caffeic Acid in Cancer Treatment.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Plants (Basel, Switzerland) · 2023
    Review
  10. Review
  11. Review
  12. Caffeic Acid and Diseases-Mechanisms of Action.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Malgorzata Tyszka-CzocharaDepartment of Radioligands, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. malgorzata.tyszka-czochara@uj.edu.pl.
Pawel KoniecznyDepartment of Transplantology, Faculty of Medicine, Jagiellonian University Medical College, Wielicka 258, 30-688 Krakow, Poland. p.konieczny@uj.edu.pl.
Marcin MajkaDepartment of Transplantology, Faculty of Medicine, Jagiellonian University Medical College, Wielicka 258, 30-688 Krakow, Poland. mmajka@cm-uj.krakow.pl.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of cancer treatments is often limited and associated with substantial toxicity. Appropriate combination of drug targeting specific mechanisms may regulate metabolism of tumor cells to reduce cancer cell growth and to improve survival. Therefore, we investigated the effects of anti-diabetic drug Metformin (Met) and a natural compound caffeic acid (

Indexed as

AMP-Activated Protein KinasesAntineoplastic AgentsApoptosisCaffeic AcidsCell CycleCell Line, TumorCell ProliferationDrug SynergismFatty AcidsFemaleGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticGlucoseHumansMetforminMitochondriaAMP-Activated Protein KinasesAntineoplastic Agentscaffeic acidCaffeic AcidsFatty AcidsGlucoseMetformin5′-adenosine monophosphate-activated protein kinase (AMPK)caffeic acidcervical cancermetabolic reprogrammingMetformin

Identifiers

PMID28230778
PMCPMC5343995
OpenAlexW2589583494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.